Relaxin Promotes Prostate Cancer Progression
Shu Feng(University of Southern California), Alexander I. Agoulnik(Florida International University), Irina U. Agoulnik(University of South Florida), Michael Ittmann(Baylor College of Medicine), Bernard Kwabi‐Addo(Howard University), Gustavo Ayala(The University of Texas Health Science Center), Natalia V. Bogatcheva(Baylor College of Medicine), Aparna A. Kamat(Baylor College of Medicine), Rile Li(Baylor College of Medicine)
Cited by 126
Related Papers
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations
|Cancer Cell|2017|656
Widespread deregulation of microRNA expression in human prostate cancer
|Oncogene|2007|635
Rethinking dog domestication by integrating genetics, archeology, and biogeography
|Proceedings of the National Academy of Sciences|2012|534
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
The role of fibroblast growth factors and their receptors in prostate cancer
|Endocrine Related Cancer|2004|353